Kristina Drott

490 total citations
24 papers, 338 citations indexed

About

Kristina Drott is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Kristina Drott has authored 24 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 13 papers in Oncology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Kristina Drott's work include Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and interferon and immune responses (4 papers). Kristina Drott is often cited by papers focused on Lymphoma Diagnosis and Treatment (9 papers), CAR-T cell therapy research (8 papers) and interferon and immune responses (4 papers). Kristina Drott collaborates with scholars based in Sweden, Denmark and Finland. Kristina Drott's co-authors include Urban Gullberg, Susanna Obad, Tor Olofsson, Åke Borg, Hans Brunnström, Johan Vallon‐Christersson, Thomas Relander, Mats Jerkeman, Nadir Mechti and Anders Lindmark and has published in prestigious journals such as Blood, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Kristina Drott

22 papers receiving 336 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kristina Drott Sweden 13 196 109 100 59 51 24 338
Moriah Gidoni Israel 12 176 0.9× 181 1.7× 35 0.3× 25 0.4× 68 1.3× 13 369
Yukiko Hiramatsu Japan 10 142 0.7× 169 1.6× 121 1.2× 41 0.7× 45 0.9× 20 381
Emily Heath Germany 4 89 0.5× 57 0.5× 88 0.9× 42 0.7× 29 0.6× 6 241
Michael Rutherford Canada 11 194 1.0× 242 2.2× 183 1.8× 23 0.4× 66 1.3× 18 418
Matilde Romero Brazil 10 93 0.5× 136 1.2× 111 1.1× 47 0.8× 40 0.8× 30 357
John Higgins United States 10 204 1.0× 253 2.3× 100 1.0× 22 0.4× 18 0.4× 18 470
Corinne Besnard‐Guérin France 8 194 1.0× 36 0.3× 51 0.5× 41 0.7× 32 0.6× 10 296
Laura Garcia‐Ibanez United Kingdom 6 111 0.6× 159 1.5× 91 0.9× 85 1.4× 20 0.4× 7 305
Iranzu González Spain 9 94 0.5× 158 1.4× 116 1.2× 24 0.4× 25 0.5× 12 355
Jaydeep Bhat Germany 11 130 0.7× 400 3.7× 219 2.2× 29 0.5× 40 0.8× 23 556

Countries citing papers authored by Kristina Drott

Since Specialization
Citations

This map shows the geographic impact of Kristina Drott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kristina Drott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kristina Drott more than expected).

Fields of papers citing papers by Kristina Drott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kristina Drott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kristina Drott. The network helps show where Kristina Drott may publish in the future.

Co-authorship network of co-authors of Kristina Drott

This figure shows the co-authorship network connecting the top 25 collaborators of Kristina Drott. A scholar is included among the top collaborators of Kristina Drott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kristina Drott. Kristina Drott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pyl, Paul Theodor, Anna Sandström Gerdtsson, Urban Gullberg, et al.. (2025). The Progression of Mycosis Fungoides During Treatment with Mogamulizumab: A BIO-MUSE Case Study of the Tumor and Immune Response in Peripheral Blood and Tissue. Biomedicines. 13(1). 186–186.
2.
Ek, Sara, et al.. (2024). Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE): Protocol for a Translational Study. JMIR Research Protocols. 13. e55723–e55723. 1 indexed citations
3.
Meriranta, Leo, Matias Autio, Harald Holte, et al.. (2024). Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas. Med. 5(6). 583–602.e5.
4.
Leppä, Sirpa, Leo Meriranta, Martti Arffman, et al.. (2023). BIOMARKER‐DRIVEN TREATMENT STRATEGY IN HIGH‐RISK LARGE B‐CELL LYMPHOMA (NLG‐LBC‐06 PHASE II TRIAL): IMPACT OF CTDNA AND TP53 ABERRATIONS ON CLINICAL OUTCOME. Hematological Oncology. 41(S2). 51–52. 1 indexed citations
5.
Gullberg, Urban, et al.. (2023). Spatially Guided and Single Cell Tools to Map the Microenvironment in Cutaneous T-Cell Lymphoma. Cancers. 15(8). 2362–2362. 8 indexed citations
6.
Leppä, Sirpa, Judit Jørgensen, Marja‐Liisa Karjalainen‐Lindsberg, et al.. (2022). Biomarker-Driven Treatment Strategy in High-Risk Large B-Cell Lymphoma: Final Results of a Nordic Phase 2 Study. Blood. 140(Supplement 1). 1768–1769. 2 indexed citations
7.
8.
Montano, Giorgia, et al.. (2017). The transcriptional coregulatorNAB2is a target gene for the Wilms' tumor gene 1 protein (WT1) in leukemic cells. Oncotarget. 8(50). 87136–87150. 3 indexed citations
9.
10.
Montano, Giorgia, et al.. (2016). Anti-apoptotic quinolinate phosphoribosyltransferase ( QPRT ) is a target gene of Wilms' tumor gene 1 (WT1) protein in leukemic cells. Biochemical and Biophysical Research Communications. 482(4). 802–807. 21 indexed citations
11.
Sandén, Carl, Giorgia Montano, Henrik Lilljebjörn, et al.. (2016). Distinct global binding patterns of the Wilms tumor gene 1 (WT1) −KTS and +KTS isoforms in leukemic cells. Haematologica. 102(2). 336–345. 11 indexed citations
12.
Gordon, Sandra, Mats Ehinger, Mats Jerkeman, et al.. (2015). Pharmacologically relevant doses of valproate upregulate CD20 expression in three diffuse large B-cell lymphoma patients in vivo. Experimental Hematology and Oncology. 4(1). 4–4. 19 indexed citations
13.
14.
15.
Lindén, Ola, et al.. (2011). Inhibition of geranylgeranylation mediates sensitivity to CHOP-induced cell death of DLBCL cell lines. Experimental Cell Research. 317(8). 1179–1191. 12 indexed citations
16.
Mörgelin, Matthias, et al.. (2009). The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase. Experimental Cell Research. 316(4). 568–579. 19 indexed citations
17.
Drott, Kristina, et al.. (2008). Identification of a novel and myeloid specific role of the leukemia‐associated fusion protein DEK‐NUP214 leading to increased protein synthesis. Genes Chromosomes and Cancer. 47(4). 276–287. 32 indexed citations
18.
Obad, Susanna, Tor Olofsson, Nadir Mechti, Urban Gullberg, & Kristina Drott. (2007). Regulation of the Interferon-Inducible p53 Target Gene TRIM22 (Staf50) in Human T Lymphocyte Activation. Journal of Interferon & Cytokine Research. 27(10). 857–864. 22 indexed citations
19.
Obad, Susanna, Tor Olofsson, Nadir Mechti, Urban Gullberg, & Kristina Drott. (2007). Expression of the IFN-inducible p53-target gene TRIM22 is down-regulated during erythroid differentiation of human bone marrow. Leukemia Research. 31(7). 995–1001. 21 indexed citations
20.
Obad, Susanna, Hans Brunnström, Johan Vallon‐Christersson, et al.. (2004). Staf50 is a novel p53 target gene conferring reduced clonogenic growth of leukemic U-937 cells. Oncogene. 23(23). 4050–4059. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Moriah Gidoni Breakdown of academic impact, for papers by Yukiko Hiramatsu Breakdown of academic impact, for papers by Emily Heath Breakdown of academic impact, for papers by Michael Rutherford Breakdown of academic impact, for papers by Matilde Romero Breakdown of academic impact, for papers by John Higgins Breakdown of academic impact, for papers by Corinne Besnard‐Guérin Breakdown of academic impact, for papers by Laura Garcia‐Ibanez Breakdown of academic impact, for papers by Iranzu González Breakdown of academic impact, for papers by Jaydeep Bhat
Rankless by CCL
2026